ranQ
ranQ
ranQ
DirectoryIndustriesPlacesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The leading AI company directory, built to boost AI visibility.

DEENFRIT
Product
  • Pricing
  • Directory
  • Industries
  • Trust Score
Company
  • About
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint745,629 companies indexed · Last updated: today
DirectoryIndustryPharmaceutical IndustryZurichVaccentis AG
Vaccentis AG Logo
Verified· 3 sourcesTrust Score
Summary

About the company

The core activity of Vaccentis AG is the development of tumor vaccines, particularly through the use of the individualized precision immunotherapy platform AIPI (ALL INDIVIDUALIZED PRECISION IMMUNOTHERAPY TUMOUR VACCINE TECHNOLOGY PLATFORM).

AI-generated
Offering

Products & services

Industry:Pharmaceutical Industry
✓ Offered3
Tumor vaccines
Protein-based tumor vaccines for the development of cancer immunotherapies; focus on individualized precision immunotherapy and the AIPI tumor vaccine technology platform.
Adjuvant therapy of renal cell carcinoma (VCC-001)
Adjuvant treatment of renal cell carcinoma with the lead candidate VCC-001; with clinical data from Phase III, evidence of efficacy and a safety profile.
Development of additional tumor vaccine candidates
Research and preclinical development of additional indications with VCC-002 for metastatic renal cell carcinoma as well as VCC-003, VCC-004 and VCC-005 for other cancer types.
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
4.1/5

Vaccentis AG

Trust & reputation

ranQ Trust Score of Vaccentis AG: 4.1 out of 5.0

Trust Score4.1/ 5.0

High

x

Data basis 58% · As of October 2026

Without public customer reviews the score stays capped.

Vaccentis AG has no value in the Reputation area of the ranQ Trust Score because no data is available. The area carries 42% of the weighting and drops out of the calculation for this profile; it does not lower the score, only the reported data basis.
x
CriterionValueWeight
  • Review quality: No data point — the criterion is taken out of the weighting and does not lower the score.—24%
  • Review volume: No data point — the criterion is taken out of the weighting and does not lower the score.—10%
  • Review recency: No data point — the criterion is taken out of the weighting and does not lower the score.—8%
Vaccentis AG scores 89.3 out of 100 points in the Substance area of the ranQ Trust Score. This area carries 28% of the weighting.
x
CriterionValueWeight
  • Establishment: Years since founding or brand launch, logarithmic. The maximum is reached at 15 years.100.012%
  • Company size: The headcount band, researched by ranQ or stated by the company. It is scored in steps rather than by head count, because the data only provides bands.70.07%
Vaccentis AG scores 86.7 out of 100 points in the Identity area of the ranQ Trust Score. This area carries 22% of the weighting.
x
CriterionValueWeight
  • Verification: Official register entry (commercial register with UID or professional-body record, 55 points), confirmed domain (20 points) and confirmed ranQ profile (up to 25 points, depending on completeness).86.722%
Vaccentis AG scores 13.6 out of 100 points in the Visibility area of the ranQ Trust Score. This area carries 8% of the weighting.
x
CriterionValueWeight
  • Website authority: Ahrefs' Domain Rating measures, on a scale of 0 to 100, how strongly a website is linked from other websites. For Swiss SMEs the range up to 40 is typical; the maximum is reached at 35.17.14%
  • Media authority: Quality and number of editorial mentions, weighted by the importance of the source, plus the recency of the latest high-quality mention.10.04%
Qualifications+0.00

Vaccentis AG reaches a ranQ Trust Score of 4.1 out of 5.0 — rated «High». No public customer reviews are available for this provider; the rating is based on the remaining criteria. The data basis is 58%, so the score is backed by part of the criteria. As of October 2026.

The Trust Score cannot be bought and is calculated from publicly verifiable data.

Press

Media

August 2, 2024Media
Sie treibt Zürcher Firma im Rennen um die Krebsimpfung an
blick.ch

Knowledge

No knowledge articles yet

Once Vaccentis AG has claimed this profile, we'll publish editorial articles and case studies here together.

Get started
Comparisons

Vaccentis AG in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank Vaccentis AG by reviews, experience and specialisations.

Is this your company?

Claim the company profile of Vaccentis AG to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Gerechtigkeitsgasse 25
8001 Zurich
Opening hours
Mon
09:00 - 17:00
Tue
09:00 - 17:00
Wed
09:00 - 17:00
Thu
09:00 - 17:00
Fri
09:00 - 17:00
Sat
Closed
Sun
Closed

At a glance

Legal form
Corporation
UID
CHE-112.970.147
Founded
2006 · 20 years
Last commercial register change
August 21, 2026
Employees
11 to 20
Legal form: Graded by liability and disclosure. The weight is kept small: a sole proprietorship is not a dubious company, it is just liable differently.
100.0
6%
  • Branch offices: Branch offices linked in the commercial register. Having none is normal and costs no points.70.03%
    • Full methodology

    Similar companies

    LB
    LimmaTech Biologics AG
    Schlieren
    BA
    Baxiva AG
    Schlieren
    BT
    BEO Therapeutics AG
    Zurich
    RA
    Redbiotec AG
    Schlieren
    NT
    NovaGo Therapeutics AG
    Schlieren
    EA
    Evax AG
    Zurich
    DG
    DeepVax GmbH
    Rämismühle
    BA
    Baxter AG
    Glattpark (Opfikon)